ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,211Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 64

$801K Total Retail Price of All Prescriptions

Rank: 2 out of 64

627 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 627 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

5% of this provider’s 627 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

0% of this provider’s 10,640 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
ATORVASTATIN CALCIUM 762 594 1 4
AMLODIPINE BESYLATE 730 661 2 5
METOPROLOL SUCCINATE 685 595 3 1
LISINOPRIL 492 348 4 2
SIMVASTATIN 459 408 5 6
METOPROLOL TARTRATE 435 386 6 3
WARFARIN SODIUM 427 381 7 9
LEVOTHYROXINE SODIUM 412 373 8 26
CRESTOR 366 286 9 10
LOSARTAN POTASSIUM 346 293 10 16
FUROSEMIDE 328 290 11 7
ATENOLOL 327 263 12 14
CLOPIDOGREL 306 230 13 12
HYDROCHLOROTHIAZIDE 298 293 14 13
PRAVASTATIN SODIUM 284 259 15 15
PANTOPRAZOLE SODIUM 250 185 16 32
DIOVAN 249 217 17 22
OMEPRAZOLE 244 196 18 33
PLAVIX 243 182 19 18
LIPITOR 208 164 20 28
NEXIUM 190 144 21 36
HYDROCODONE-ACETAMINOPHEN 158 140 S3 22 40
KLOR-CON M20 157 119 23 34
NITROSTAT 157 130 23 25
ISOSORBIDE MONONITRATE ER 153 116 25 11
ZOLPIDEM TARTRATE 149 115 26 41
DILTIAZEM 24HR ER 129 104 27 23
TRAZODONE HCL 111 76 28 45
POTASSIUM CHLORIDE 98 95 29 42
CARVEDILOL 93 65 30 8
CITALOPRAM HBR 89 65 31 47
TRAMADOL HCL 85 42 32 48
METFORMIN HCL 85 67 32 48
LOSARTAN-HYDROCHLOROTHIAZIDE 83 79 34 50
VENLAFAXINE HCL ER 78 18 35 52
ALLOPURINOL 76 61 36 54
PAROXETINE HCL 75 63 37 55
AMIODARONE HCL 69 69 38 24
ESCITALOPRAM OXALATE 66 44 39 57
SPIRONOLACTONE 65 48 40 19
SOTALOL 64 60 41 20
DILTIAZEM ER 62 62 42 35
BYSTOLIC 60 55 43 37
TAMSULOSIN HCL 59 59 44 60
TRICOR 57 37 45 46
DILTIAZEM HCL 55 49 46 61
DIGOXIN 54 50 47 17
ZETIA 50 43 48 21
RANITIDINE HCL 50 31 48 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.